Highlights and Quick Summary
- Annual Cash ROIC for 2021 was -31.46% (a -10.83% decrease from previous year)
- Annual Cash ROIC for 2020 was -35.28% (a 52.4% increase from previous year)
- Annual Cash ROIC for 2019 was -23.15% (a 45.32% increase from previous year)
- Twelve month Cash ROIC ending September 30, 2022 was -39.44% (a 23.6% increase compared to previous quarter)
- Twelve month trailing Cash ROIC increased by 32.93% year-over-year
Trailing Cash ROIC for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| -39.44% | -31.91% | -37.83% | -29.67% |
Visit stockrow.com/BBIO
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Cash ROIC of BridgeBio Pharma, Inc.
Most recent Cash ROICof BBIO including historical data for past 10 years.Interactive Chart of Cash ROIC of BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. Cash ROIC for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2021 | – | – | – | – | -31.46% |
| 2020 | – | – | – | – | -35.28% |
| 2019 | – | – | – | – | -23.15% |
| 2018 | – | – | – | – | -15.93% |
| 2017 | – | – | – | – | -17.16% |
Business Profile of BridgeBio Pharma, Inc.
Sector: Healthcare
Industry: Biotechnology